AbbVie to Present at Bernstein's 37th Annual Strategic Decisions Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in Bernstein's 37th Annual Strategic Decisions Conference on June 2, 2021, at 2:30 p.m. Central Time. Presenters will include Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and CFO. A live audio webcast will be available on AbbVie's Investor Relations website, with an archived edition posted later the same day. AbbVie is committed to developing innovative medicines across various therapeutic areas, including immunology, oncology, and neurology.

News Market Reaction – ABBV

+0.12%

+0.12% Session move

In the trading session that priced this news, ABBV gained 0.12%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., May 26, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Bernstein's 37^th Annual Strategic Decisions Conference on Wednesday, June 2, 2021. Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and chief financial officer, will present virtually at 2:30 p.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-bernsteins-37th-annual-strategic-decisions-conference-301299171.html

SOURCE AbbVie

FAQ

When is AbbVie's presentation at Bernstein's 37th Annual Strategic Decisions Conference?

AbbVie's presentation will take place on June 2, 2021, at 2:30 p.m. Central Time.

Who will be presenting for AbbVie at the conference?

Michael Severino, M.D., and Robert A. Michael will present for AbbVie.

Where can I access the live webcast of AbbVie's presentation?

The live webcast will be available on AbbVie's Investor Relations website.

What is AbbVie's mission?

AbbVie's mission is to discover and deliver innovative medicines that tackle serious health issues and medical challenges.

What therapeutic areas does AbbVie focus on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.